Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Bo Hansen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapyNiels Fisker, Majken Westergaard, Henrik Frydenlund Hansen, et al.
Nucleosides, Nucleotides & Nucleic Acids|January 12, 2008
Synthesis and biological evaluation of LNA phosphoramidatesJacob Jensen, Gitte Sjøgren, Jens Bo Hansen, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Antisense knockdown of PKC-alpha using LNA-oligosJens Bo Hansen, Majken Westergaard, Charlotte Albaek Thrue, et al.
Nucleic Acids Research|June 8, 2004
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1Fabien Darfeuille, Jens Bo Hansen, Henrik Orum, et al.
Biochemistry|September 28, 2006
Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotidesFabien Darfeuille, Sandrine Reigadas, Jens Bo Hansen, et al.
Nucleic Acids Research|July 15, 2009
Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSFJesper Worm, Jan Stenvang, Andreas Petri, et al.
Molecular Cancer Therapeutics|September 16, 2008
SPC3042: a proapoptotic survivin inhibitorJens Bo Hansen, Niels Fisker, Majken Westergaard, et al.
Nucleic Acids Research|December 26, 2007
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liverJoacim Elmén, Morten Lindow, Asli Silahtaroglu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapyNiels Fisker, Majken Westergaard, Henrik Frydenlund Hansen, et al.
Nucleosides, Nucleotides & Nucleic Acids|January 12, 2008
Synthesis and biological evaluation of LNA phosphoramidatesJacob Jensen, Gitte Sjøgren, Jens Bo Hansen, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Antisense knockdown of PKC-alpha using LNA-oligosJens Bo Hansen, Majken Westergaard, Charlotte Albaek Thrue, et al.
Nucleic Acids Research|June 8, 2004
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1Fabien Darfeuille, Jens Bo Hansen, Henrik Orum, et al.
Biochemistry|September 28, 2006
Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotidesFabien Darfeuille, Sandrine Reigadas, Jens Bo Hansen, et al.
Nucleic Acids Research|July 15, 2009
Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSFJesper Worm, Jan Stenvang, Andreas Petri, et al.
Molecular Cancer Therapeutics|September 16, 2008
SPC3042: a proapoptotic survivin inhibitorJens Bo Hansen, Niels Fisker, Majken Westergaard, et al.
Nucleic Acids Research|December 26, 2007
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liverJoacim Elmén, Morten Lindow, Asli Silahtaroglu, et al.
Pageof 1